Efficacy and safety of simultaneous immunomagnetic CD34+ cell selection and breast cancer cell purging in peripheral blood progenitor cell samples used for hematopoietic rescue after high-dose therapy

Clinical Cancer Research

Volumn 5, Issue 5, 1999, Pages 1035-1040

  Mohr, Michael ^b   Hilgenfeld, Eva ^b   Fietz, Thomas ^c   Hoppe, Berthold ^c   Koenigsmann, Michael ^c   Hoffmann, Marianne ^c   Knauf, Wolfgang U ^c   Cassens, Uwe ^b   Sibrowski, Walter ^b   Kienast, Joachim ^b   Thiel, Eckhard ^c   Berdel, Wolfgang E ^a,b  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CYCLOPHOSPHAMIDE; EPIRUBICIN; GRANULOCYTE COLONY STIMULATING FACTOR; PACLITAXEL; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ARTICLE; BONE MARROW RESCUE; BREAST CANCER; CANCER CHEMOTHERAPY; CELL SELECTION; CELL SEPARATION; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOCYTOCHEMISTRY; LEUKAPHERESIS; LEUKOCYTE COUNT; LYMPHOCYTE DEPLETION; LYMPHOCYTE SUBPOPULATION; PRIORITY JOURNAL; THROMBOCYTE COUNT;

ANTIGENS, CD34; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CARBOPLATIN; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; EPIRUBICIN; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOMAGNETIC SEPARATION; LEUKAPHERESIS; MITOXANTRONE; NEOPLASM CIRCULATING CELLS; NEOPLASM METASTASIS; PACLITAXEL; THIOTEPA;

EID: 0032902189     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Zittoun, R. A., Mandelli, F., Willemze, R., de Witte, T., Labar, B., Resegotti, L., Leoni, F., Damasio, E., Visani, G., Papa, G., Caronia, F., Hayat, M., Stryckmans, P., Rotoli, P., Leoni, P., Peetermans, M. E., Dardenne, M., Luce Vegna, M., Concetta Petti, M., Solbu, D., and Suciu, S. Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. N. Engl. J. Med., 332: 217-223, 1995.
2. Linch, D. C., Winfield, D., Goldstone, A. H., Moir, D., Hancock, B., McMillan, A., Chopra, R., Milligan, D., and Hudson, G. V. Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial. Lancet, 341: 1051-1054, 1993.
3. Philip, T., Guglielmi, C., Hagenbeek, A., Somers, R., Van der Lelie, H., Bron, D., Sonneveld, P., Gisselbrecht, C., Cahn, J. Y., Harousseau, J. L., Coiffier, B., Biron, P., Mandelli, F., and Chauvin, F. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. N. Engl. J. Med., 333: 1540-1545, 1995.
4. Haioun, C., Lepage, E., Gisselbrecht, C., Bastion, Y., Coiffier, B., Brice, P., Bosly, A., Dupriez, B., Nouvel, C., Tilly, H., Lederlin, P., Biron, P., Briere, J., Gaulard, P., and Reyes, F. Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: updated results of the prospective study LNH87-2. J. Clin. Oncol., 15; 1131-1137, 1997.
5. Attal, M., Harousseau, J. L., Stoppa, A. M., Sotto, J. J., Fuzibet, J. G., Rossi, J. F., Casassus, P., Maisonneuve, H., Facon, T., Ifrah, N., Payen, C., and Bataille R. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. N. Engl. J. Med., 335: 91-97, 1996.
6. Bezwoda, W. R., Seymour, L., and Dansey, R. D. High-dose chemotherapy with hematopoietic rescue as primary treatment for metastatic breast cancer: a randomized trial. J. Clin. Oncol., 13: 2483-2489, 1995.
7. Beyer, J., Schwella, N., Zingsem, J., Strohscheer, I., Schwaner, I., Oettle, H., Serke, S., Huhn, D., and Siegert, W. Hematopoietic rescue after high-dose chemotherapy using autologous peripheral-blood progenitor cells or bone marrow: a randomized comparison. J. Clin. Oncol., 13: 1328-1335, 1995.
8. Schmitz, N., Linch, D. C., Dreger, P., Goldstone, A. H., Boogaerts, M. A., Ferrant, A., Demuynck, H. M. S., Link, H., Zander, A., Barge, A., and Borkett, K. Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients. Lancet, 347: 353-357, 1996.
9. Ager, S., Scott, M. A., Mahendra, P., Richards, E. M., Jestice, H. K., Boraks, P., Baglin, T. P., and Marcus, R. E. Peripheral blood stem cell transplantation after high-dose therapy in patients with malignant lymphoma: a retrospective comparison with autologous bone marrow transplantation. Bone Marrow Transplant., 16: 79-83, 1995.
10. Ross, A. A., Cooper, B. W., Lazarus, H. M., Mackay, W., Moss, T. J., Ciobanu, N., Tallman, M. S., Kennedy, M. J., Davidson, N. E., Sweet, D., Winter, C., Akard, L., Jansen, J., Copelan, E., Meagher, R. C., Herzig, R. H., Klumpp, T. R., Kahn, D. G., and Warner, N. E. Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques. Blood, 82: 2605-2610, 1993.
11. Antman, K. H., Rowlings, P. A., Vaughan, W. P., Pelz, C. J., Fay, J. W., Fields, K. K., Freytes, C. O., Gale, R. P., Hillner, B. E., Holland, H. K., Kennedy, M. J., Klein, J. P., Lazarus, H. M., McCarthy, P. L., Saez, R., Spitzer, G., Stadtmauer, E. A., Williams, S. F., Wolff, S., Sobocinski, K. A., Armitage, J. O., and Horowitz, M. M. High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America. J. Clin. Oncol., 15: 1870-1879, 1997.
12. Diel, I. J., Kaufmann, M., Costa, S. D., Holle, R., von Minckwitz, G., Solomayer, E. F., Kaul, S., and Bastert, G. Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status. J. Natl. Cancer Inst. (Bethesda), 88: 1652-1659, 1996.
13. Brugger, W., Bross, K. J., Glatt, M., Weber, F., Mertelsmann, R., and Kanz, L. Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors. Blood, 83: 636-640, 1994.
14. Mapara, M. Y., Körner, I. J., Hildebrandt, M., Bargou, R., Krahl, D., Reichardt, P., and Dörken, B. Monitoring of tumor cell purging after highly efficient immunomagnetic selection of CD34 cells from leukapheresis products in breast cancer patients: comparison of immunocytochemical tumor cell staining and reverse transcriptase-polymerase chain reaction. Blood, 89: 337-344, 1997.
15. Shpall, E. J., and Jones, R. B. Release of tumor cells from bone marrow. Blood, 83: 623-625, 1994.
16. Gribben, J. G., Freedman, A. S., Neuberg, D., Roy, D. C., Blake, K. W., Woo, S. D., Grossbard, M. L., Rabinowe, S. N., Coral, F., Freeman, G. J., Ritz, J., and Nadler, L. M. Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma. N. Engl. J. Med., 325: 1525-1533, 1991.
17. Gorin, N. C., Aegerter, P., Auvert, B., Meloni, G., Goldstone, A. H., Burnett, A., Carella, A., Korbling, M., Herve, P., Maraninchi, D., Löwenberg, R., Verdonck, L. F., de Planque, M., Hermans, J., Helbig, W., Porcellini, A., Rizzoli, V., Alesandrino, E. P., Franklin, I. M., Reiffers, J., Colleselli, P., and Goldman, J. M. Autologous bone marrow transplantation for acute myelocytic leukemia in first remission: a European survey of the role of marrow purging. Blood, 75: 1606-1614, 1990.
18. Brockstein, B., Ross, A., Hollingsworth, K., Grinblatt, D., and Williams, S. Tumor cell contamination of bone marrow harvest products: clinical consequences in a cohort of advanced breast cancer patients undergoing high dose chemotherapy (HDC). Proc. ASCO, 14: 327, 1995.
19. Sharp, J. G., Kessinger, A., Mann, S., Crouse, D. A., Armitage, J. O., Bierman, P., and Weisenburger, D. D. Outcome of high-dose therapy and autologous transplantation in non-Hodgkin's lymphoma based on the presence of tumor in the marrow or infused hematopoietic harvest. J. Clin. Oncol., 14: 214-219, 1996.
20. Brenner, M. K., Rill, D. R., Moen, R. C., Krance, R. A., Mirro, J., Anderson, W. F., and Ihle, J. N. Gene-marking to trace origin of relapse after autologous bone-marrow transplantation. Lancet, 341: 85-86, 1993.
21. Deisseroth, A. B., Zu, Z., Claxton, D., Hanania, E. G., Fu, S., Ellerson, D., Goldberg, L., Thomas, M., Janicek, K., Anderson, W. F., Hester, J., Korbling, M., Durret, A., Moen, R., Berenson, R., Heimfeld, S., Hamer, J., Calvert, L., Tibbits, P., Talpaz, M., Kantarjian, H., Champlin, R., and Reading, C. Genetic marking shows that Ph+ cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML. Blood, 83: 3068-3076, 1994.
22. Rill, D. R., Santana, V. M., Roberts, W. M., Nilson, T., Bowman, L. C., Krance, R. A., Heslop, H. E., Moen, R. C., Ihle, J. N., and Brenner, M. K. Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicity of tumorigenic cells. Blood, 84: 380-383, 1994.
23. Kvalheim, G. Purging of autografts: methods and clinical significance. Ann. Med., 28: 167-173, 1996.
24. Roots-Weiss, A., Papadimitriou, C., Serve, H., Hoppe, B., Koenigsmann, M., Reufi, B., Oberberg, D., Thiel, E., and Berdel, W. E. The efficiency of tumor cell purging using immunomagnetic CD34+ cell separation systems. Bone Marrow Transplant., 19: 1239-1246, 1997.
25. Bertolini, F., Thomas, T., Battaglia, M., Gibelli, N., Pedrazzoli, P., and Robustelli della Cuna, G. A new "two step" procedure for 4.5 log depletion of T and B cells in allogeneic transplantation and of neoplastic cells in autologous transplantation. Bone Marrow Transplant., 19: 615-619, 1997.
26. Paulus, U., Schmitz, N., Viehmann, K., von Neuhoff, N., and Dreger, P. Combined positive/negative selection for highly effective purging of PBPC grafts: towards clinical application in patients with B-CLL. Bone Marrow Transplant., 20: 415-420, 1997.
27. Vogler, W. R., Berdel, W. E., Olson, A. C., Winton, E. F., Heffner, L. T., and Gordon, D. S. Autologous bone marrow transplantation in acute leukemia with marrow purged with alkyl-lysophospholipid. Blood, 80: 1423-1429, 1992.
28. Koenigsmann, M. P., Notter, M., Knauf, W. U., Papadimitriou, C. A., Oberberg, D., Reufi, B., Mücke, C., Thiel, E., and Berdel, W. E. Chemopurging of peripheral blood-derived progenitor cells by alkyl-lysophospholipid and its effect on haematopoietic rescue after high-dose therapy. Bone Marrow Transplant., 18: 549-557, 1996.
29. Shpall, E. J., Bast, R. C., Joines, W. T., Jones, R. B., Anderson, I., Johnston, C., Eggleston, S., Tepperberg, M., Edwards, S., and Peters, W. P. Immunomagnetic purging of breast cancer from bone marrow for autologous transplantation. Bone Marrow Transplant., 7: 145-151, 1991.
30. Dietzfelbinger, H. F., Kühn, D., Zafferani, M., Hanauske, A. R., Rastetter, J. W., and Berdel, W. E. Removal of breast cancer cells from bone marrow by in vitro purging with ether lipids and cryopreservation. Cancer Res., 53: 3747-3751, 1993.
31. Pedrazzoli, P., Battaglia, M., Da Prada, G. A., Lanza, A., Cuomo, A., Bertolini, F., Pavesi, L., and Robustelli della Cuna, G. Role of tumor cells contaminating the graft in breast cancer recurrence after high-dose chemotherapy. Bone Marrow Transplant., 20: 167-169, 1997.
32. Anderson, I. C., Shpall, E. J., Leslie, D. S., Nustad, K., Ugelstad, J., Peters, W. P., and Bast, R. C. Elimination of malignant clonogenic breast cancer cells from human bone marrow. Cancer Res., 49: 4659-4664, 1989.
33. Papadimitriou, C. A., Roots, A., Koenigsmann, M., Oelmann, E., Topp, M. S., Oberberg, D., Reufi, B., Thiel, E., and Berdel, W. E. Fresh peripheral blood mononuclear cell preparations are a better starting material than bone marrow after cryopreservation for immunomagnetic harvesting of CD34+ hematopoietic cells. Int. J. Oncol., 9: 1107-1112, 1996.
34. Papadimitriou, C. A., Roots, A., Koenigsmann, M., Koenigsmann, M., Mücke, C., Oelmann, E., Oberberg, D., Reufi, B., Thiel, E., and Berdel, W. E. Immunomagnetic selection of CD34+ cells from fresh peripheral blood mononuclear cell preparations using two different separation techniques. J. Hematother., 4: 539-544, 1995.
35. Dietzfelbinger, H. F., Lang, A., Oberberg, D., Rastetter, J. W., and Berdel, W. E. Differential cytotoxicity of an ether lipid on lymphoma and bone marrow cells and its role in purging malignant lymphoid cells from remission bone marrow contaminated with tumor cells. Exp. Hematol., 20: 178-183, 1992.
36. Shpall, E. J., Jones, R. B., Bast, R. C., Rosner, G. L., Vandermark, R., Ross, M., Affronti, M. L., Johnston, C., Eggleston, S., Tepperberg, M., Coniglio, D., and Peters, W. P. 4-Hydroperoxycyclophosphamide purging of breast cancer from the mononuclear cell fraction of bone marrow in patients receiving high-dose chemotherapy and autologous marrow support: a Phase I trial. J. Clin. Oncol., 9: 85-93, 1991.
37. Passos-Coelho, J., Ross, A. A., Davis, J. M., Huelskamp, A. M., Clarke, B., Noga, S. J., Davidson, N. E., and Kennedy, M. J. Bone marrow micrometastases in chemotherapy-responsive advanced breast cancer: effect of ex vivo purging with 4-hydroperoxycyclophosphamide. Cancer Res., 54: 2366-2371, 1994.
38. Myklebust, A. T., Godal, A., Juell, S., Pharo, A., and Fodstad, O. Comparison of two antibody-based methods for elimination of breast cancer cells from human bone marrow. Cancer Res., 54: 209-214, 1994.
39. Treleaven, J. G., Gibson, F. M., Ugelstad, J., Rembaum, A., Philip, T., Caine, G. D., and Kemshead, J. T. Removal of neuroblastoma cells from bone marrow with monoclonal antibodies conjugated to magnetic microspheres. Lancet, i: 70-73, 1984.
40. Shpall, E. J., Jones, R. B., Bearman, S. I., Franklin, W. A., Archer, P. G., Curiel, T., Bitter, M., Claman, H. N., Stemmer, S. M., Purdy, M., Myers, S. E., Hami, L., Taffs, S., Heimfeld, S., Hallagan, J., and Berenson, R. J. Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment. J. Clin. Oncol., 12: 28-36, 1994.
41. Brugger, W., Henschler, R., Heimfeld, S., Berenson, R. J., Mertelsmann, R., and Kanz, L. Positively selected autologous blood CD34+ cells and unseparated peripheral blood progenitor cells mediate identical hematopoietic engraftment after high-dose VP16, ifosfamide, carboplatin, and epirubicin. Blood, 84: 1421-1426, 1994.
42. Stewart, A. K., Vescio, R., Schiller, G., Ballester, O., Noga, S., Rugo, H., Freytes, C., Stadtmauer, E., Sahebi, F., Tarantolo, S., Stiff, P., Meharchard, J., Schlossman, R., Brown, R., Tully, H., Sing, A., Jacobs, C., Dipersio, J., Anderson, K., and Berenson, J. Phase III study evaluating CD34 selected versus unselected autologous peripheral blood progenitor cell transplantation in 190 patients with advanced multiple myeloma. Blood, 92 (Suppl. 1): 662a, 1998.
43. Vredenburgh, J., Shpall, E. J., Ross, M., Meisenberg, B., Bast, R., Tyer, C., Tepperberg, M., Eggleston, S., and Peters, W. P. Immunopharmacologic bone marrow purging and high-dose chemotherapy with autologous bone marrow support (ABMS) for patients with metastatic breast cancer. Proc. ASCO, 11: 58, 1992.